Evidence map›Paper›PMID 40450102›Full record

ArticleMikrochimica acta2025

A FRET-based aptasensor exploiting the multiple functions of zirconium-based bimetallic organic frameworks for the quantitative determination of sulfadimethoxine.

Masoomeh Esmaelpourfarkhani, Mahshid Olfati Sumar, Mohammad Ramezani, Mona Alibolandi, Khalil Abnous, Seyed Mohammad Taghdisi

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Masoomeh EsmaelpourfarkhaniPharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahshid Olfati SumarDepartment of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad RamezaniPharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Mona AlibolandiPharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Khalil AbnousPharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. abnouskh@mums.ac.ir.
Seyed Mohammad TaghdisiTargeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. taghdisihm@mums.ac.ir.

Funding

National Institute for Medical Research Development 4021336
6 · The paper itself

Abstract

A novel fluorescent aptasensor was introduced for the assessment of sulfadimethoxine (SDM) using multiple functions of ZrFe metal-organic framework (MOF). This sensing strategy exploits the ZrFe MOF features including the peroxidase-mimicking feature, fluorescence characteristics, single-stranded DNA adsorption on its surface, and the change in its catalytic activity. In the detection mechanism, ferrofluid was used as separation agent and the peroxidized product quenched the fluorescence intensity of the ZrFe MOF through the fluorescence resonance energy transfer (FRET) effect. In this FRET-based approach, the existence or absence of SDM affects the attendance or non-attendance of complementary strand of aptamer (CS) in supernatant solution, which subsequently alters the peroxidase-like behavior of ZrFe MOF. Thus, the discrepancy in fluorescence intensity is caused by the variation in the amount of produced peroxidation product. Employing this sensing platform, a detection limit of 3 pM was achieved. Furthermore, the suggested sensing platform, leveraging the specificity of the aptamer for its target, demonstrated a significant potential to mitigate the influence of other interfering substances. The aptasensor has the capability to quantitatively detect SDM content in human serum samples. Therefore, it is well-suited for use in intricate matrices.

Indexed as

Aptamers, NucleotideBiosensing TechniquesFluorescence Resonance Energy TransferMetal-Organic FrameworksSulfadimethoxineZirconiumFluorescent DyesHumansLimit of DetectionAptamers, NucleotideFluorescent DyesMetal-Organic FrameworksSulfadimethoxineZirconiumFerrofluidFluorescent methodSulfadimethoxineZrFe MOF

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.